TG THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tg Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Tg Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $2.29M, a 19.6% decline year-over-year.
  • Tg Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $12.1M, a 16.3% increase year-over-year.
  • Tg Therapeutics, Inc. annual Interest Expense for 2023 was $12.6M, a 23.8% increase from 2022.
  • Tg Therapeutics, Inc. annual Interest Expense for 2022 was $10.2M, a 80.8% increase from 2021.
  • Tg Therapeutics, Inc. annual Interest Expense for 2021 was $5.64M, a 10.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $12.1M $2.29M -$556K -19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $12.6M $2.43M -$431K -15.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $13M $3.71M +$2.07M +125% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $11M $3.63M +$610K +20.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $10.4M $2.84M +$180K +6.76% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $10.2M $2.86M +$1.78M +165% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $8.41M $1.65M +$610K +58.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $7.8M $3.02M +$1.39M +85.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $6.4M $2.66M +$766K +40.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $5.64M $1.08M -$211K -16.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $5.85M $1.04M -$572K -35.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $6.42M $1.62M -$605K -27.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.03M $1.9M +$697K +58% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $6.33M $1.29M -$609K -32.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $6.94M $1.61M +$73K +4.75% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $6.87M $2.23M +$1.15M +107% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $5.71M $1.2M +$427K +55.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $5.29M $1.9M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.54M +$1.32M +595% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.08M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $774K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $221K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q3 2016 $917K $212K -$35K -14.2% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $952K $221K -$25.8K -10.5% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $977K $242K +$4.75K +2% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $973K $242K +$7.24K +3.08% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 $965K $247K +$11.7K +5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $954K $247K +$11.7K +5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $942K $238K +$11.3K +5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $931K $235K -$6.09K -2.53% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $937K $235K -$5.74K -2.39% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $943K $235K -$5.23K -2.18% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $948K $226K -$5.13K -2.22% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $953K $241K +$12K +5.23% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $941K $241K +$11.9K +5.23% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $929K $240K +$11.9K +5.22% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-24
Q1 2013 $917K $231K +$11.3K +5.14% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $906K $229K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 $229K +$229K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $228K +$228K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $220K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $0 +$350K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $0 -$351K -100% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-07
Q3 2010 -$350K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $351K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.